Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Physician-Scientist Development
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • In-Press Preview
    • Resource and Technical Advances
    • Clinical Research and Public Health
    • Research Letters
    • Editorials
    • Perspectives
    • Physician-Scientist Development
    • Reviews
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Resource and Technical Advances
  • Clinical Research and Public Health
  • Research Letters
  • Editorials
  • Perspectives
  • Physician-Scientist Development
  • Reviews
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
IL-13 promotes functional recovery after myocardial infarction via direct signaling to macrophages
Santiago Alvarez-Argote, Samantha J. Paddock, Michael A. Flinn, Caelan W. Moreno, Makenna C. Knas, Victor A. Almeida, Sydney L. Buday, Amirala Bakhshian Nik, Michaela Patterson, Yi-Guang Chen, Chien-Wei Lin, Caitlin C. O’Meara
Santiago Alvarez-Argote, Samantha J. Paddock, Michael A. Flinn, Caelan W. Moreno, Makenna C. Knas, Victor A. Almeida, Sydney L. Buday, Amirala Bakhshian Nik, Michaela Patterson, Yi-Guang Chen, Chien-Wei Lin, Caitlin C. O’Meara
View: Text | PDF
Research Article Cardiology

IL-13 promotes functional recovery after myocardial infarction via direct signaling to macrophages

  • Text
  • PDF
Abstract

There is great interest in identifying signaling pathways that promote cardiac repair after myocardial infarction (MI). Prior studies suggest a beneficial role for IL-13 signaling in neonatal heart regeneration; however, the cell types mediating cardiac regeneration and the extent of IL-13 signaling in the adult heart after injury are unknown. We identified an abundant source of IL-13 and the related cytokine, IL-4, in neonatal cardiac type 2 innate lymphoid cells, but this phenomenon declined precipitously in adult hearts. Moreover, IL-13 receptor deletion in macrophages impaired cardiac function and resulted in larger scars early after neonatal MI. By using a combination of recombinant IL-13 administration and cell-specific IL-13 receptor genetic deletion models, we found that IL-13 signaling specifically to macrophages mediated cardiac functional recovery after MI in adult mice. Single transcriptomics revealed a subpopulation of cardiac macrophages in response to IL-13 administration. These IL-13–induced macrophages were highly efferocytotic and were identified by high IL-1R2 expression. Collectively, we elucidated a strongly proreparative role for IL-13 signaling directly to macrophages following cardiac injury. While this pathway is active in proregenerative neonatal stages, reactivation of macrophage IL-13 signaling is required to promote cardiac functional recovery in adults.

Authors

Santiago Alvarez-Argote, Samantha J. Paddock, Michael A. Flinn, Caelan W. Moreno, Makenna C. Knas, Victor A. Almeida, Sydney L. Buday, Amirala Bakhshian Nik, Michaela Patterson, Yi-Guang Chen, Chien-Wei Lin, Caitlin C. O’Meara

×

Figure 1

Macrophage (Mφ) IL-4Rα deletion impairs neonatal cardiac repair.

Options: View larger image (or click on image) Download as PowerPoint
Macrophage (Mφ) IL-4Rα deletion impairs neonatal cardiac repair.
(A) Rep...
(A) Representative histogram plots of IL-4Rα expression in cardiac Mφ isolated from IL-4Rαfl/fl and IL-4RαMacKO mice at 4 dpi after P1 MI. FMO–IL-4Rα control is also shown. (B) Quantification of IL-4Rα MFI in infiltrating Mφ, resident Mφ, and lymphoid cells. (C) Experimental scheme of P1 MI, BrdU injections on 5 and 7 dpi, heart collections for histology at 8 dpi, cardiac echocardiogram (Echo), and heart collection for histology at 21 dpi. (D) Representative images showing Gömöri trichrome staining of mouse hearts at 8 and 21 dpi. Scale bar: 1 mm. (E and F) Quantification of total scar area in mm2 of mice at 8 dpi and 21 dpi. (G) Representative images of Mef2/PCNA immunostaining of cardiac sections at 8 dpi after P1 MI. Arrowheads indicate PCNA+/Mef2+ cells. White box inset indicates zoomed-in region. (H) Quantification of PCNA+/Mef2+ cells as a percentage of total Mef2+ nuclei quantified. (I) Quantification of BrdU+/NKX2.5+ cells (staining not shown) as a percentage of total Nkx2.5+ nuclei quantified. (J) Quantification of LV ejection fraction of mice at 21 dpi after P1 MI or age-matched uninjured conditions. (K) Representative images of CD31, WGA, and DAPI staining of mouse hearts at 21 dpi after P1 MI. (L and M) Quantification of capillary density and capillary size at the BZ and RZ of mouse hearts at 21 dpi. Data are presented as mean ± SD. Each data point represents 1 mouse. *P < 0.05, **P < 0.01, ***P < 0.001, ****P < 0.0001. Comparison by unpaired 2-tailed t test in B, E, F, H, I, L, and M. Interaction of condition (uninjured versus 21 dpi) and genotype effect by 2-way ANOVA and Sidak’s post hoc test for IL-4RαMacKO versus other 2 genotypes in J.

Copyright © 2026 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts